A comparison of Symbicort [Budesonide/formoterol] single inhaler therapy (Symbicort turbuhaler 160/4.5mg, 1 inhalation b.i.d. plus as needed) and conventional best practice [antiasthmatics] for the treatment of persistent asthma in adults a -26-week, randomized, open-label, parallel-group, multicentre study
Phase of Trial: Phase III
Latest Information Update: 13 Aug 2012
At a glance
- Drugs Antiasthmatics; Budesonide/formoterol
- Indications Asthma
- Focus Therapeutic Use
- Acronyms PASSION
- 29 Dec 2008 Actual end date (1 Sep 2008) added as reported by ClinicalTrials.gov.
- 21 Mar 2008 New trial record.